Archives

by in
Entry Author Date Location
J&J, GSK, Tekmira, And Others Take Next Steps To Fight Ebola 10/22/14 Boston
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
Brazil: Ready for Future Growth in Health Care 07/09/14 Seattle
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Sarepta Moves From Seattle to Boston for the Talent 09/07/12 Seattle
Sarepta Holds Its Breath as Feds Order Halt to Ebola Work 08/07/12 Seattle
Theraclone Passes First Clinical Test with Flu-Fighting Antibody 05/15/12 Seattle
IDRI, Aeras Team Up to Develop Tuberculosis Vaccine 05/09/12 Seattle
Cardeas Gears Up for Clinic, With Drug Combo for Hospital Infections 04/26/12 Seattle
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
Novartis, Trying Not to Burn the Hamburger, Increases its Bet on the Bay Area 04/19/11 San Francisco
NanoBio Nabs $6M from Gates Foundation for Nasal Spray Vaccine 11/30/10 Detroit
Genzyme to Let Diagnostics Unit Loose for $265M 11/18/10 Boston
Trius, Developer of Antibiotic for Deadly MRSA Bacteria, Passes Key Test 06/08/09 San Diego
UMass Lab in $60M Merck Deal 04/21/09 Boston
Adventrx Pharma Shutting Down 03/23/09 San Diego
Regulus, Leading Developer of MicroRNA Drugs, Prepares to Get Independence from Alnylam and Isis 01/21/09 San Diego
U.S. Genomics Gets $4.5M, Enters Partnership 09/23/08 Boston
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration 09/02/08 Boston
Spaltudaq Harnessing Mother Nature’s Wisdom to Make Better Drugs For Infections 08/28/08 Seattle
Page 1 of 1